Lima Memorial Health System welcomed a second Tru-D SmartUVC to its infection prevention team.
With the generous support of PotashCorp, LMHS purchased its first Tru-D SmartUVC robot in August and has b
een using the technology daily to disinfect patient areas before surgery at the hospital, as well as in the hospital’s isolation rooms, as a part of the terminal cleaning process. Community members rallied together at a recent fundraising event, sponsored by the Lima Memorial Foundation, to fund a second disinfecting robot.
The health care leaders at LMHS aren’t the only ones to recognize Tru-D’s effectiveness as of late. In October, research leaders in UVC disinfection released the results of the first randomized clinical trial on UVC disinfection, in which Tru-D SmartUVC was the only device used. Overall, results of the landmark Benefits of Enhanced Terminal Room Disinfection study, which was funded by the Centers for Disease Control and Prevention, showed that enhanced terminal room disinfection strategies decreased the cumulative incidence of multidrug-resistant organisms by 10 to 30%, and the largest decreases were seen when Tru-D was added to the standard cleaning strategy, (Daniel J. Sexton, MD, et al., 2015). It also showed that the process of incorporating Tru-D into hospital disinfection protocols for highest risk rooms was seamless, and adding a cycle of UVC dosing only added up to 10 minutes to the total room turnover.
Tru-D
tru-d.com
